Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Cerebral Palsy: Short-burst Interval Training

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03373890
Recruitment Status : Completed
First Posted : December 14, 2017
Results First Posted : July 10, 2019
Last Update Posted : July 10, 2019
Sponsor:
Collaborator:
Louisiana State University Health Sciences Center in New Orleans
Information provided by (Responsible Party):
Kristie Bjornson, Seattle Children's Hospital

Brief Summary:
This study examines the effect of short burst interval treadmill training in ambulatory children with cerebral palsy. Half the sample will receive 20 sessions of training over 4 weeks, while half will receive the training over 10 weeks.

Condition or disease Intervention/treatment Phase
Cerebral Palsy Spastic Diplegia Behavioral: Short Burst Interval Locomotor Treadmill Training (SBLTT) Not Applicable

Detailed Description:

Ambulatory children with cerebral palsy (CP) experience activity limitations which negatively influence their ability to physically participate in day to day life. Therefore, these children are at greater risk for inactivity and functional decline with age. In contrast, typically developing (TD) children engage in short bursts of intense physical activity interspersed with varying intervals of low and moderate intensity within their natural environment. These physical activity patterns are very different from adult patterns Despite these inherent differences, locomotor treadmill training (LTT) protocols designed to improve walking activity in children with CP simulate adult protocols, consisting of continuous low to moderate walking endurance activity. Body weight supported or robot assisted LTT is based on the underlying premise of modifying neural circuitry via spinal pathways. However, this type of training has not been shown to be more effective than other comparable interventions and presents with significant fiscal and logistical barriers to clinical translation.

This study will determine the effect of short-burst interval LTT without body weight support on the primary outcomes of walking performance and capacity and the secondary outcomes of day-to-day mobility based participation in children with CP with functional walking limitations. To identify key muscular mechanisms associated with improved walking mobility, the investigators will examine the effects of short-burst interval LTT on quadriceps muscle performance and architecture. Secondarily, the study team will collect preliminary data on two LTT dosing frequencies.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 12 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: Pre/post intervention design with participants randomized to two different frequency of intervention
Masking: Single (Outcomes Assessor)
Masking Description: Muscle function assessor masked to frequency group, Muscle architecture captured via ultrasound Community walking activity collected by accelerometry, thus non-human data collection
Primary Purpose: Treatment
Official Title: Muscle Performance and Walking in Cerebral Palsy: Short-burst Interval Training
Actual Study Start Date : August 1, 2014
Actual Primary Completion Date : July 31, 2016
Actual Study Completion Date : July 31, 2016

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Short burst Interval Treadmill Training High Frequency
Participants receive short burst interval treadmill training for a total of 20 sessions. They are randomized to receive it either 5x/week for 4 weeks
Behavioral: Short Burst Interval Locomotor Treadmill Training (SBLTT)
SBLTT consists of interval training consisting of short-bursts (30 seconds) of vigorous intensity locomotor treadmill training (LTT) alternating with low to moderate intensity LTT.,

Active Comparator: Short Burst Interval Treadmill Training Low Frequency
Participants receive short burst interval treadmill training for a total of 20 sessions. They are randomized to receive it either 2x/week for 10 weeks
Behavioral: Short Burst Interval Locomotor Treadmill Training (SBLTT)
SBLTT consists of interval training consisting of short-bursts (30 seconds) of vigorous intensity locomotor treadmill training (LTT) alternating with low to moderate intensity LTT.,




Primary Outcome Measures :
  1. Change in Walking Performance High Versus Low Frequency SBLTT Groups [ Time Frame: Change from baseline to immediately post SBLTT ]
    Average stride per day as measured by StepWatch accelerometry. StepWatch accelerometer stride counts per day ( minimum of 8 hrs/day wearing time) were averaged a crossed 5 days (4 weekdays and 1 weekend day) to create Average Strides/day variable

  2. Change in Community Walking Performance Intensity High Versus Low Frequency SBLTT Groups [ Time Frame: Change from baseline to immediately post SBLTT ]
    Average Strides/day > 30 strides/min as measured by StepWatch accelerometry High Versus Low Frequency SBLTT Groups

  3. Change in Walking Capacity High Versus Low Frequency SBLTT Groups [ Time Frame: Change from baseline to immediately post SBLT. ]
    Self selected walking speed as measured by 10 meter walk test High Versus Low Frequency SBLTT Groups

  4. Change in Walking Endurance- High Versus Low Frequency SBLTT Groups [ Time Frame: Change from baseline to immediately post SBLTT ]
    Distance walked during the One Minute Walk Test High Versus Low Frequency SBLTT Groups


Secondary Outcome Measures :
  1. Change in Muscle Performance -Power High Versus Low Frequency SBLTT Groups [ Time Frame: Change from baseline to 6 weeks post SBLTT ]
    Knee extensor muscle power - isotonic muscle power as measured by Biodex testing High Versus Low Frequency SBLTT Groups

  2. Change in Muscle Performance - Strength High Versus Low Frequency SBLTT Groups [ Time Frame: Change from baseline to immediately post SBLTT ]
    Knee extensor muscle strength - isometric muscle strength as measured by Biodex testing High Versus Low Frequency SBLTT Groups

  3. Change in Muscle Architecture-High Versus Low Frequency SBLTT Groups [ Time Frame: Change from baseline to immediately post SBLTT ]
    Rectus femoris mid thigh cross-sectional area as measured by 2D B Mode Ultrasound High Versus Low Frequency SBLTT Groups

  4. Change in Muscle Architecture-hypertrophy High Versus Low Frequency SBLTT Groups [ Time Frame: Change from baseline to immediately post SBLTT ]
    Rectus femoris mid thigh fascicle length as measured by 2D B Mode Ultrasound High Versus Low Frequency SBLTT Groups



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   5 Years to 12 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Ambulatory children with cerebral palsy Spasticity primary movement disorder Bilateral motor impairment (Diplegia) Gross Motor Function Classification System Levels II and III

Exclusion Criteria:

  • undergone orthopedic or neurosurgery less than 12 months prior injection therapies (phenol, botulinum toxin) less than 3 months prior

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03373890


Locations
Layout table for location information
United States, Washington
Seattle Children's Research Institute
Seattle, Washington, United States, 98115
Sponsors and Collaborators
Seattle Children's Hospital
Louisiana State University Health Sciences Center in New Orleans
Investigators
Layout table for investigator information
Study Director: James Hendricks, PhD Seattle Children's Research Institute
Layout table for additonal information
Responsible Party: Kristie Bjornson, Associate Professor, Pediatrics, Seattle Children's Hospital
ClinicalTrials.gov Identifier: NCT03373890    
Other Study ID Numbers: R21HD077186 ( U.S. NIH Grant/Contract )
First Posted: December 14, 2017    Key Record Dates
Results First Posted: July 10, 2019
Last Update Posted: July 10, 2019
Last Verified: June 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Cerebral Palsy
Nervous System Diseases
Brain Damage, Chronic
Brain Diseases
Central Nervous System Diseases